Mysimba

Human medicines European public assessment report (EPAR): Terrosa, teriparatide, Date of authorisation: 04/01/2017, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Karvea, irbesartan, Date of authorisation: 26/08/1997, Revision: 49, Status: Authorised

Human medicines European public assessment report (EPAR): Tauvid, flortaucipir (18F), Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Guidance for rapporteurs and members of drafting groups of documents developed by the GMP/GDP Inspectors Working Group

Human medicines European public assessment report (EPAR): Cyramza, ramucirumab, Date of authorisation: 19/12/2014, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Amyvid, florbetapir (18F), Date of authorisation: 14/01/2013, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Abiraterone Krka, abiraterone acetate, Date of authorisation: 24/06/2021, Revision: 5, Status: Authorised

Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 13-14 January 2026

Veterinary medicines European public assessment report (EPAR): Lotilaner / Milbemycin Elanco, lotilaner,milbemycin oxime, Status: Opinion